Thomas Jaki
researcher
Facts
9 properties- Instance of
- human
- Occupation
- researcher
- Employer
- University of Cambridge (2020–present), University of Regensburg (2022–present)[2][3]
- Educated at
- University of South Carolina[4]
- Doctoral advisor
- Ronald Webster West[5]
- Doctoral student
- Matthew Sperrin, Dominic Magirr, Pavel Mozgunov[7][8][9]
- Imported from
- wholeness_audit_2026-05-02
🏷️ Also known as
en Thomas Jaki
🔖 Identifiers · 5
- ORCID iD
- 0000-0002-1096-188X
- OpenAlex ID
- A5053252382, A5062431908, A5125180733as of 2026-09-23
where from?
- Source
- OpenAlex
- Edition
- 20260923 · as of 2026-09-23
- Licence
- CC0 1.0 Universal
- Bronze
- not in the catalog
- Transform
- 4ort-mint · openalex:20260923 · version not recorded
- MR Author ID
- 790046
- Mathematics Genealogy Project ID
- 108839
- Scopus author ID
- 9846641800
📜 Data licence
Source: OpenAlex (openalex.org), snapshot of 2026-09-23. CC0 1.0 Universal. CC0 1.0 Universal · OpenAlex
🔗 Connections
Author of 10
An Information Theoretic Phase I–II Design for Molecularly Targeted Agents That Does Not Require an Assumption of Monotonicity,
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design,
Estimation in multi-arm two-stage trials with treatment selection and time-to-event endpoint,
Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses,
Impact of an equality constraint on the class-specific residual variances in regression mixtures: A Monte Carlo simulation study,
Online error rate control for platform trials,
Optimizing subgroup selection in two‐stage adaptive enrichment and umbrella designs,
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol
+2 more
← Authored by 10
An Information Theoretic Phase I–II Design for Molecularly Targeted Agents That Does Not Require an Assumption of Monotonicity,
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design,
Estimation in multi-arm two-stage trials with treatment selection and time-to-event endpoint,
Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses,
Impact of an equality constraint on the class-specific residual variances in regression mixtures: A Monte Carlo simulation study,
Online error rate control for platform trials,
Optimizing subgroup selection in two‐stage adaptive enrichment and umbrella designs,
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol
+2 more
Press Enter · cited answer in seconds
0 sources
Summary
Thomas Jaki worked as a researcher[1].
Body
Career and Affiliations
Employers include University of Cambridge[2], a collegiate university[11], in United Kingdom[12], founded in 1209[13], headquartered in Cambridge[14] and University of Regensburg[3], a public university[15], in Germany[16], founded in 1962[17], headquartered in Regensburg[18]. Doctoral students include Matthew Sperrin[7]; Dominic Magirr[8]; and Pavel Mozgunov[9], a researcher[19].
FAQs
What did Thomas Jaki do for work?
Thomas Jaki worked as researcher[1].
Where did Thomas Jaki go to school?
Thomas Jaki was educated at University of South Carolina[4].